Acquisition

Owen Mumford Expands Pelvic Health Portfolio with Empelvic Acquisition

Medical device company Owen Mumford has recently announced the acquisition of Empelvic, a brand specializing in pelvic floor cushion technology. This strategic move aims to bolster Owen Mumford’s pelvic and sexual health portfolio, catering to the growing demand for accessible at-home solutions for intimate health conditions. Empelvic, founded in Denmark by Gry Senderovitz and Michael Severinsen, offers a non-invasive pelvic floor cushion…

Canadian Digital Health Company Dialogue Expands Women’s Health Offering Through Acquisition of Koble’s Assets

Canadian virtual healthcare and wellness platform Dialogue has recenlty announced the acquisition of certain assets of Koble, a digital health startup supporting women’s health. The acquisition includes Koble’s suite of proprietary content, software, and intellectual property, which will be integrated into Dialogue’s Integrated Health Platform (IHP). Swati Matta, Founder and CEO of Koble, will join Dialogue’s team as Head of Women’s Health,…

Amazon Aggregator Forum Brands Acquires Organic Period Care Brand Lola

Forum Brands, an aggregator specializing in Amazon-focused brands, has acquired Lola, a company known for its organic period care products. Lola, established in 2014 by Alexandra Friedman and Jordana Kier, differentiates itself in the market with its 100% organic cotton tampons, pads, and sanitary products. The acquisition, terms of which were not disclosed, aligns with Forum Brands’ strategy to expand in health…

Pharma Company IBSA Acquires Aura Fertility to Bolster IVF Patient Support

IBSA, a pharma company actively involved in reproductive health, has acquired Aura Fertility, an app with the goal of improving the IVF experience. This move is in line with IBSA’s goal to improve patient experiences and outcomes in fertility by focusing on the emotional aspects and challenges associated with IVF. London-based Aura Fertility was established in 2020 by Abi Hannah, Karen Hanson,…

Compass Diversified Partners with The Honey Pot Company in $380M Deal to Expand Feminine Care Offerings

Compass Diversified (CODI), known for its portfolio of leading middle-market businesses, has entered into a partnership with The Honey Pot Company, a brand specializing in “better-for-you” feminine care products. The agreement, which carries an enterprise value of $380 million, aims to reinforce The Honey Pot Company’s commitment to providing comprehensive and holistic feminine care systems. Originating from a personal need for healthier…

Dr. Reddy’s Acquires Menopause Supplement Brand MenoLabs from Amyris in Chapter 11 Auction

Dr. Reddy’s Laboratories, a global pharmaceutical company headquartered in India, has acquired MenoLabs, a women’s health and dietary supplement brand, as part of Amyris Chapter 11 sales process. This acquisition was conducted through an auction, with Dr. Reddy’s successfully bidding $3 million for the women’s supplements label according to court documents. MenoLabs’ portfolio, now a part of Dr. Reddy’s offerings, includes seven…

Cosette Acquires HSDD Treatment Vyleesi from Palatin for $12M Amid Market Challenges

Cosette Pharmaceuticals has acquired Vyleesi, the FDA-approved treatment for Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women, from Palatin Technologies. The transaction, valued at $12 million with an additional $159 million in contingent sales-based milestones, reflects Cosette’s strategic expansion in women’s health despite the drug’s struggling performance in the market. Vyleesi, once anticipated to be a breakthrough akin to “female Viagra,” has…

Lunit Targets US Market with $193M Acquisition of AI-Enabled Breast Cancer Detection Platform Volpara

Lunit, a South Korean company that recently secured $150M, has announced its plan to acquire Volpara Health Technologies, an AI-enabled software company specializing in the early detection and prevention of cancer. The acquisition, which is expected to be completed by the second quarter of 2024, involves Lunit acquiring all Volpara shares at AUD 1.15 per share, amounting to a deal worth approximately…